Panagora Asset Management Inc Adaptimmune Therapeutics PLC Transaction History

Panagora Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$3.86 - $5.78 $23,063 - $34,535	-5,975 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$4.9 - $6.83 $5,752 - $8,018	-1,174 Reduced 16.42%	5,975 $32,000
Q4 2020 Feb 10, 2021	SELL	$4.0 - $9.2 $700 - $1,609	-175 Reduced 2.39%	7,149 $39,000
Q3 2020 Nov 13, 2020	SELL	$7.66 - $10.78 $50,081 - $70,479	-6,538 Reduced 47.16%	7,324 $58,000
Q2 2020 Aug 12, 2020	SELL	$2.58 - $12.1 $11,878 - $55,708	-4,604 Reduced 24.93%	13,862 $139,000
Q4 2019 Feb 12, 2020	BUY	$0.72 - $1.43 $13,295 - $26,406	18,466 New	18,466 $22,000

150M

60.8K

5.8K

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $98M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.